San Francisco, California
United States
42
2025-07-03
34
2025-12-09
These are the the leading inventors for applications assigned to Genentech, Inc:
Genentech, Inc based in San Francisco, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
DETERMINING A PATIENT’S RESPONSE TO A TREATMENT IN MULTIPLE MYELOMA
#2 | 2023-04-20PREDICTION OF PEPTIDE CLEAVAGE IN POLYPEPTIDES THROUGH PHYSICS-BASED SIMULATIONS
#3 | 2021-05-27 ✅ Patent 12,492,247 granted on 2025-12-09Antibody Formulations
#4 | 2020-07-09 ✅ Patent 11,827,639 granted on 2023-11-28TDO2 and IDO1 inhibitors
#5 | 2019-10-31 ✅ Patent 11,844,938 granted on 2023-12-19Apparatus and methods for low-volume medicament delivery
#6 | 2017-03-30 ✅ Patent 10,351,595 granted on 2019-07-16Macrocyclic broad spectrum antibiotics
#7 | 2014-10-02 ✅ Patent 9,821,074 granted on 2017-11-21Pyrrolobenzodiazepines and conjugates thereof
#8 | 2013-02-14 ✅ Patent 9,428,548 granted on 2016-08-30Enhanced protein purification through a modified protein A elution
#9 | 2012-11-29COILED COIL AND/OR TETHER CONTAINING PROTEIN COMPLEXES AND USES THEREOF
#10 | 2012-11-08 ✅ Patent 9,321,823 granted on 2016-04-26Mutant smoothened and methods of using the same
#11 | 2012-07-26 ✅ Patent 8,999,998 granted on 2015-04-07Pyrazolopyrimidine JAK inhibitor compounds and methods
#12 | 2012-03-15 ✅ Patent 9,221,900 granted on 2015-12-29Methods for identifying safe and functional humanized antibodies
#13 | 2012-02-23Composition and Methods for the Diagnosis and Treatment of Tumor
#14 | 2011-10-27TREATMENT METHOD
#15 | 2010-11-25 ✅ Patent 7,960,118 granted on 2011-06-14EGFR mutations
#16 | 2010-03-11METHODS AND COMPOSITIONS FOR MODULATING HEPSIN ACTIVATION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR
#17 | 2009-11-05 ✅ Patent 7,741,096 granted on 2010-06-22Crystal structure of hepatocyte growth factor activator complexed with Kunitz domain inhibitor
#18 | 2009-10-01 ✅ Patent 7,928,248 granted on 2011-04-19Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use
#19 | 2009-08-27 ✅ Patent 8,067,199 granted on 2011-11-29Anti-IL13 antibodies and uses thereof
#20 | 2009-07-16 ✅ Patent 8,303,955 granted on 2012-11-06Humanized anti-CD40 antibodies and their methods of use
#21 | 2008-10-09Dr5 Antibodies and Uses Thereof
#22 | 2008-07-29 ✅ Patent 7,405,268 granted on 2008-07-29Secreted and transmembrane polypeptides and nucleic acids encoding the same
#23 | 2008-04-08 ✅ Patent 7,354,997 granted on 2008-04-08Polypeptide encoded by a nucleic acid underexpressed in stomach tumor
#24 | 2008-03-18 ✅ Patent 7,345,145 granted on 2008-03-18Secreted and transmembrane polypeptides and nucleic acids encoding the same
#25 | 2007-11-29 ✅ Patent 8,329,169 granted on 2012-12-11Methods and compositions for the prevention and treatment of sepsis
#26 | 2007-11-13 ✅ Patent 7,294,495 granted on 2007-11-13PR03580 polypeptides
#27 | 2007-10-23 ✅ Patent 7,285,626 granted on 2007-10-23PRO1076 polypeptides
#28 | 2007-09-04 ✅ Patent 7,264,817 granted on 2007-09-04Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
#29 | 2007-08-14 ✅ Patent 7,256,262 granted on 2007-08-14Secreted and transmembrane polypeptides and nucleic acids encoding the same
#30 | 2007-08-07 ✅ Patent 7,253,256 granted on 2007-08-07Polypeptides encoded by a nucleic acid are expressed in esophageal and kidney tumor
#31 | 2007-07-03 ✅ Patent 7,238,787 granted on 2007-07-03Antibodies to a polypeptide encoded by a nucleic acid underexpressed in melanoma
#32 | 2007-06-12 ✅ Patent 7,230,077 granted on 2007-06-12Polypeptide encoded by a nucleic acid underexpressed in melanoma
#33 | 2007-06-05 ✅ Patent 7,227,000 granted on 2007-06-05Secreted and transmembrane polypeptides and nucleic acids encoding the same
#34 | 2007-03-27 ✅ Patent 7,196,166 granted on 2007-03-27Secreted polypeptide overexpressed in rectal tumor
#35 | 2007-03-20 ✅ Patent 7,193,062 granted on 2007-03-20Antibodies to a polypeptide encoded by a nucleic acid over expressed in esoprageal and lung tumor, and under expressed in kidney tumor and melanoma
#36 | 2007-03-20 ✅ Patent 7,193,046 granted on 2007-03-20Polypeptide encoded by a nucleic acid overexpressed in esophageal and lung tumor, and underexpressesd in kidney tumor and melanoma
#37 | 2007-03-20 ✅ Patent 7,193,060 granted on 2007-03-20Antibodies to a polypeptides encoded by a nucleic acid overexpressed in kidney tumor and underexpressed in lung tumor
#38 | 2007-03-20 ✅ Patent 7,193,059 granted on 2007-03-20Antibodies that recognize a polypeptide overexpressed in rectal tumors
#39 | 2007-03-13 ✅ Patent 7,189,804 granted on 2007-03-13PRO1335 polypeptides
#40 | 2006-05-11 ✅ Patent 7,351,543 granted on 2008-04-01Antibodies to a polypeptide encoded by a nucleic acid underexpressed in melanoma
#41 | 2005-10-20 ✅ Patent 7,649,082 granted on 2010-01-19Persephin specific antibodies
#42 | 2005-04-14Synthetic antibody phage libraries
Also check out Genentech, Inc.'s (San Francisco, United States) applicant profile with 3 patent applications submitted.
9637 ⎘